Alivus Life Sciences Limited (NSE:ALIVUS)
India
· Delayed Price · Currency is INR 920.50
+0.75 (0.08%)
Mar 10, 2026, 9:40 AM IST
Alivus Life Sciences Revenue
Alivus Life Sciences had revenue of 6.73B INR in the quarter ending December 31, 2025, with 4.84% growth. This brings the company's revenue in the last twelve months to 25.12B, up 10.48% year-over-year. In the fiscal year ending March 31, 2025, Alivus Life Sciences had annual revenue of 23.87B with 4.54% growth.
Revenue (ttm)
25.12B
Revenue Growth
+10.48%
P/S Ratio
4.49
Revenue / Employee
11.40M
Employees
2,203
Market Cap
112.89B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cohance Lifesciences | 10.79B |
| Alembic Pharmaceuticals | 72.67B |
| Strides Pharma Science | 47.26B |
| Akums Drugs and Pharmaceuticals | 42.60B |
| NATCO Pharma | 45.63B |
| Eris Lifesciences | 30.65B |
| Piramal Pharma | 88.71B |
| Wockhardt | 31.74B |